News

AddToAny

Google+ Facebook Twitter Twitter

How cancer cells use competition to evade the body’s defences

A Japanese team of scientists has examined the effects of the accumulation of stepwise gene mutations on cell competition and investigated its role in the cancer formation process.

The study results showed that when Wnt signals were activated in epithelial cells, cell competition function was altered. Activated Ras mutant epithelial cells, which would normally be eliminated into the lumen, instead infiltrated diffusely into the tissue to form highly invasive cancerous tumours.

Senior author Professor Shunsuke Kon said: “We discovered that in epithelial tissues where Wnt and Ras signals, which commonly occur in human colorectal cancer, are activated in stages, the function of cell competition is altered.

It was revealed that the production of cancer cells that diffusely infiltrate into the interstitium is promoted.”

The research team identified an increased expression of matrix metalloproteinase 21 (MMP21) as one of the mechanisms underlying the production of diffusely invasive cancer cells in early colorectal cancer due to abnormal cell competition. This, in turn, was shown to be directly caused by activation of nuclear factor kappa B (NF-κB) signals via the innate immune system. Blocking NF-κB signalling restored the luminal elimination of Ras mutant epithelial cells.

These findings raise questions, such as: “How do surrounding cells recognise transformed cells and prepare them for cellular extrusion?” and  “How do transformed cells sense the cellular content that leads to the NF-κB-MMP21 pathway?”

The results of this research show that cancer cells with accumulated, sequential genetic mutations, alter the function of cell competition and use it to enhance their own invasive ability.

bit.ly/3sQQFSP

Image credit | Shutterstock

Related Articles

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Specialist diploma in molecular pathology

On behalf of the members of the Molecular Pathology Advisory Panel, Chair Dr Andrew Blann introduces the new Specialist Diploma.

The role of organelle repair in fighting infection

Research has found that cellular structures act as “molecular plasters” that protect against infections, such as tuberculosis. We talk to study co-author Claudio Bussi.

Top